Suppr超能文献

乳腺癌:胃肠道转移和癌病女性患者的临床表现及干预措施

Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis.

作者信息

McLemore Elisabeth C, Pockaj Barbara A, Reynolds Carol, Gray Richard J, Hernandez Jose L, Grant Clive S, Donohue John H

机构信息

Division of General Surgery, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, USA.

出版信息

Ann Surg Oncol. 2005 Nov;12(11):886-94. doi: 10.1245/ASO.2005.03.030. Epub 2005 Sep 21.

Abstract

BACKGROUND

Breast cancer metastatic to the gastrointestinal tract or peritoneum is rare. We reviewed the natural history of ductal and lobular carcinoma in women with breast cancer metastatic to the gastrointestinal tract, peritoneum, or both.

METHODS

We performed a retrospective review of all patients (1985-2000) with a pathologic diagnosis of breast cancer metastatic to the gastrointestinal tract or peritoneum. Patients were categorized into three groups: those with gastrointestinal metastasis, carcinomatosis, or both.

RESULTS

Of 73 patients, 23 (32%) had gastrointestinal metastasis only, 32 (44%) had carcinomatosis only, and 18 (25%) had both. The median age at initial breast cancer diagnosis was 55 years. The mean interval between the primary diagnosis and metastatic presentation was 7 years. Sites of gastrointestinal metastases included the esophagus (8%), stomach (28%), small intestine (19%), and colon and rectum (45%). Infiltrating lobular carcinoma represented 34 (64%) of the 53 gastrointestinal metastases. The median overall survival after diagnosis was 28 months. Palliative surgical intervention in 47 patients (64%) did not affect overall survival. Some survival benefit may have accrued to select patients with gastrointestinal metastasis who underwent surgical palliation (44 vs. 9 months). Advanced age at diagnosis and gastric metastases had a negative effect on survival, whereas treatment with systemic chemotherapy or tamoxifen had a positive effect on survival.

CONCLUSIONS

Gastrointestinal metastasis occurred more often in patients with invasive lobular carcinoma. Surgical intervention did not significantly extend overall survival but may be considered in a select group of patients.

摘要

背景

乳腺癌转移至胃肠道或腹膜较为罕见。我们回顾了乳腺癌转移至胃肠道、腹膜或两者的女性患者中导管癌和小叶癌的自然病史。

方法

我们对所有(1985 - 2000年)经病理诊断为乳腺癌转移至胃肠道或腹膜的患者进行了回顾性研究。患者被分为三组:胃肠道转移组、癌性腹膜炎组或两者皆有的组。

结果

73例患者中,23例(32%)仅发生胃肠道转移,32例(44%)仅发生癌性腹膜炎,18例(25%)两者皆有。初次诊断乳腺癌时的中位年龄为55岁。初次诊断与出现转移之间的平均间隔时间为7年。胃肠道转移部位包括食管(8%)、胃(28%)、小肠(19%)以及结肠和直肠(45%)。在53例胃肠道转移病例中,浸润性小叶癌占34例(64%)。诊断后的中位总生存期为28个月。47例患者(64%)接受的姑息性手术干预并未影响总生存期。部分接受手术姑息治疗的胃肠道转移患者可能获得了生存益处(44个月对9个月)。诊断时年龄较大和胃转移对生存有负面影响,而全身化疗或他莫昔芬治疗对生存有正面影响。

结论

浸润性小叶癌患者更常发生胃肠道转移。手术干预并未显著延长总生存期,但可考虑用于特定患者群体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验